Lin, H Y

Potentiation by thyroxine of interferon-gamma-induced antiviral state requires PKA and PKC activities. [electronic resource] - The American journal of physiology Oct 1996 - C1256-61 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

0002-9513

10.1152/ajpcell.1996.271.4.C1256 doi


Animals
Calmodulin--pharmacology
Carbazoles
Cyclic AMP--physiology
Cyclic AMP-Dependent Protein Kinase Type II
Cyclic AMP-Dependent Protein Kinases--antagonists & inhibitors
Dose-Response Relationship, Drug
Drug Synergism
Enzyme Inhibitors--pharmacology
Estrenes--pharmacology
HeLa Cells
Humans
Indoles--pharmacology
Interferon-gamma--administration & dosage
L Cells
Mice
Protein Kinase C--antagonists & inhibitors
Pyrroles--pharmacology
Pyrrolidinones--pharmacology
Rhabdoviridae Infections--physiopathology
Staurosporine--analogs & derivatives
Sulfonamides--pharmacology
Tetradecanoylphorbol Acetate--pharmacology
Thyroxine--administration & dosage
Time Factors
Vesicular stomatitis Indiana virus
Viral Interference--drug effects